Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A (2006) 8.27

The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol (2009) 5.21

Immune signaling by RIG-I-like receptors. Immunity (2011) 5.02

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med (2005) 4.92

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med (2008) 3.62

Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol (2005) 3.59

Regulation of innate immune responses in the brain. Nat Rev Immunol (2009) 3.41

Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol (2006) 3.15

Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis (2005) 3.15

PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol (2006) 3.13

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med (2005) 3.08

Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med (2008) 3.08

Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog (2006) 3.04

TLR signaling is required for Salmonella typhimurium virulence. Cell (2011) 2.88

Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity (2009) 2.66

Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol (2008) 2.62

Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol (2006) 2.57

Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog (2007) 2.54

West Nile virus infection and immunity. Nat Rev Microbiol (2013) 2.40

Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev (2008) 2.39

IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog (2010) 2.39

Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet (2009) 2.35

West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol (2006) 2.32

CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol (2006) 2.31

Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol (2007) 2.30

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev (2009) 2.30

The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation (2005) 2.23

Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest (2009) 2.18

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis (2008) 2.14

Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med (2006) 2.11

The pathogenesis of Rift Valley fever. Viruses (2011) 2.02

Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci (2011) 2.01

Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol (2008) 1.93

RNase L plays a role in the antiviral response to West Nile virus. J Virol (2006) 1.92

Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res (2006) 1.91

Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends. Clin Microbiol Rev (2005) 1.91

Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol (2006) 1.84

Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut (2005) 1.84

Pattern recognition receptors and the innate immune response to viral infection. Viruses (2011) 1.82

A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci U S A (2008) 1.75

Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol (2005) 1.75

West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol (2008) 1.75

Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med (2015) 1.74

Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) (2011) 1.73

Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A (2007) 1.71

Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med (2011) 1.71

Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol (2010) 1.69

MDA-5 recognition of a murine norovirus. PLoS Pathog (2008) 1.68

Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog (2011) 1.68

IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog (2013) 1.67

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med (2007) 1.64

The structural immunology of antibody protection against West Nile virus. Immunol Rev (2008) 1.63

2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog (2012) 1.62

Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol (2007) 1.61

Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med (2009) 1.60

Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol (2008) 1.57

Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest (2007) 1.57

Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol (2012) 1.54

Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol (2008) 1.49

West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology (2009) 1.49

Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog (2012) 1.48

Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J Virol (2008) 1.48

Innate immune recognition and activation during HIV infection. Retrovirology (2010) 1.45

TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice. J Clin Invest (2012) 1.44

CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease? J Neuroimmune Pharmacol (2009) 1.43

Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav Immun (2007) 1.40

Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res (2010) 1.40

West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev (2012) 1.38

Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 1.38

The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol (2010) 1.38

Toll-like receptor 5-deficient mice have dysregulated intestinal gene expression and nonspecific resistance to Salmonella-induced typhoid-like disease. Infect Immun (2008) 1.37

IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog (2009) 1.35

Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun (2010) 1.33

Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One (2009) 1.31

MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog (2011) 1.31

Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology (2007) 1.28

MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol (2010) 1.28

Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem (2011) 1.27

TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol (2008) 1.26

Progress on the development of therapeutics against West Nile virus. Antiviral Res (2009) 1.26

Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology (2009) 1.25

Adjuvant-specific regulation of long-term antibody responses by ZBTB20. J Exp Med (2014) 1.25

The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat Rev Immunol (2014) 1.25

Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest (2012) 1.24

Toll-like receptors: key players in antiviral immunity. Curr Opin Virol (2011) 1.24

TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest (2012) 1.24

Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol (2011) 1.23

Mammalian Toll-like receptors: to immunity and beyond. Clin Exp Immunol (2005) 1.23

Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol (2007) 1.23

Interferon-stimulated genes: roles in viral pathogenesis. Curr Opin Virol (2014) 1.22

TLR3 immunity to infection in mice and humans. Curr Opin Immunol (2013) 1.22

Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J Gen Virol (2009) 1.22

West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22

Alterations in the Aedes aegypti transcriptome during infection with West Nile, dengue and yellow fever viruses. PLoS Pathog (2011) 1.22

Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids (2009) 1.22

Manifold mechanisms of Toll-like receptor-ligand recognition. J Clin Immunol (2005) 1.22

West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol (2012) 1.21

Virus infections in the nervous system. Cell Host Microbe (2013) 1.21

West Nile virus: crossing the blood-brain barrier. Nat Med (2004) 1.19

Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J Immunol (2010) 1.17

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75

Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol (2006) 9.53

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 9.16

Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A (2004) 9.00

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A (2006) 8.27

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88

MAP kinases in the immune response. Annu Rev Immunol (2001) 7.62

Interchromosomal associations between alternatively expressed loci. Nature (2005) 7.45

IRAK-M is a negative regulator of Toll-like receptor signaling. Cell (2002) 6.79

T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity (2007) 6.61

Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature (2007) 6.58

Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science (2006) 6.55

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol (2007) 6.20

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity (2006) 6.00

Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A (2005) 5.96

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature (2002) 5.95

Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity (2006) 5.91

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity (2007) 5.73

The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A (2008) 5.59

Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell (2004) 5.50

Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature (2005) 5.32

A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol (2009) 5.26

A toll-like receptor that prevents infection by uropathogenic bacteria. Science (2004) 5.26

Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science (2009) 5.24

Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest (2009) 5.09

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity (2012) 5.08

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med (2007) 4.95

RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A (2004) 4.88

TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science (2005) 4.86

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med (2005) 4.85

The NLR gene family: a standard nomenclature. Immunity (2008) 4.77

The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol (2006) 4.70

Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat Immunol (2004) 4.67

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity (2008) 4.67

TGF-beta: a master of all T cell trades. Cell (2008) 4.60

Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature (2003) 4.60

Transforming growth factor-beta in T-cell biology. Nat Rev Immunol (2002) 4.50

Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med (2007) 4.47

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol (2006) 4.44

T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med (2005) 4.28

Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med (2006) 4.28

Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol (2003) 4.15

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature (2002) 4.15

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12

Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity (2007) 4.07

Control of TH17 cells occurs in the small intestine. Nature (2011) 4.03

Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity (2006) 4.02

Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer (2013) 4.02

Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A (2009) 3.99

Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp Med (2006) 3.76

Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A (2006) 3.74

The inflammasome: first line of the immune response to cell stress. Cell (2006) 3.73

Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe (2007) 3.52

STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A (2003) 3.46

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med (2005) 3.43

The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity (2012) 3.43

ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med (2008) 3.39

Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity (2011) 3.38

OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest (2004) 3.38

Mechanism of p38 MAP kinase activation in vivo. Genes Dev (2003) 3.36

T helper cell differentiation: regulation by cis elements and epigenetics. Immunity (2006) 3.33

Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell (2006) 3.32

Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity (2008) 3.26

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A (2004) 3.26

Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol (2010) 3.25

Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity (2007) 3.19

Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med (2008) 3.15

JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science (2012) 3.12

The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol (2002) 3.08

Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog (2006) 3.04

Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation. J Immunol (2002) 3.04

Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med (2004) 3.02

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol (2005) 2.96

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A (2003) 2.94

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest (2008) 2.91

Regulation of the Th2 cytokine locus by a locus control region. Immunity (2003) 2.84

A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe (2010) 2.84

Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med (2004) 2.84

Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology (2007) 2.82

An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity (2009) 2.82

The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature (2005) 2.82

Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med (2002) 2.77